Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Healthtrust
Federal Trade Commission
Moodys
Teva
UBS
Cipla
Harvard Business School
Merck

Pharmaceutical companies with the most 'New Product Exclusivity' drugs

This chart shows the companies which have received the most New Product exclusivities in the past five years.

New Product Development is one of the categories for which the FDA grants three years of exclusivity for 'New Clinical Investigations.'

Alternate categories worth of three years of protection include identifying a New Patient Population, New Dosage Form, or New Strength.

The companies with the most New Product exclusivities are:

Back to Pharmaceutical Industry Infographics

For more information try a trial or see the plans and pricing